LEGN (Legend Biotech) Shares Buyback Ratio %: -4.98 (As of Sep. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LEGN Legend Biotech Corp LEGN
71 GF Score
Price $18.64
GF Value $80.41
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Legend Biotech Shares Buyback Ratio %?

Legend Biotech LEGN -2.89% 71 Shares Buyback Ratio % is -4.98 as of Sep. 13, 2026. GuruFocus rates LEGN with a GF Score™ of 71/100 and a GF Value™ of $80.41 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Legend Biotech's current shares buyback ratio was -4.98%.

Legend Biotech Shares Buyback Ratio % Related Terms

Legend Biotech Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Legend Biotech's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Legend Biotech Shares Buyback Ratio % Chart

Legend Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Buyback Ratio %
Get a 7-Day Free Trial -15.96 -7.03 -10.20 -0.96 -0.70

Legend Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -0.06 -0.14 -0.43 -4.32
LEGN
71GF Score
Legend Biotech Corp LEGN
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Legend Biotech Shares Buyback Ratio % Calculation

Legend Biotech's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(183.649 - 184.943) / 183.649
=-0.70%

Legend Biotech's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2026 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Mar. 2026 )
=(185.740 - 193.769) / 185.740
=-4.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -4.98 mean?
Legend Biotech (LEGN) has a Shares Buyback Ratio % of -4.98 as of Sep. 13, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Legend Biotech and its competitors.
Is Legend Biotech's Shares Buyback Ratio % too high?
Legend Biotech's current Shares Buyback Ratio % is -4.98. Overall, Legend Biotech has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Legend Biotech's Shares Buyback Ratio % compare to IDYA and DNLI?
Legend Biotech's Shares Buyback Ratio % of -4.98 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Legend Biotech and its competitors. Legend Biotech's current Shares Buyback Ratio % is -4.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Legend Biotech stock overvalued right now?
Based on GuruFocus' analysis, Legend Biotech (LEGN) is currently considered Significantly Undervalued. The stock's GF Value™ is $80.41, compared to a current price of $18.64 — trading 76.8% below its estimated fair value. The current Shares Buyback Ratio % is -4.98. Legend Biotech's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Legend Biotech (LEGN), the current Shares Buyback Ratio % is -4.98 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Legend Biotech (LEGN) Overvalued in 2026?

Based on GuruFocus' analysis, Legend Biotech stock appears to be undervalued. The current stock price of $18.64 is trading 76.8% below its estimated GF Value™ of $80.41. GuruFocus considers Legend Biotech to be Significantly Undervalued.

Key valuation signals for LEGN:

  • Shares Buyback Ratio %: -4.98
  • GF Value™: $80.41 vs. price of $18.64 (76.8% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the LEGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Legend Biotech Business Description

Other Exchanges 9LB:Germany
Address 2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
71GF Score

Get the complete analysis for LEGN

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.64
Price
$80.41
GF Value